Amplitude Surgical SAS

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0012789667
EUR
6.25
-0.05 (-0.79%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Negative results in Dec 24

  • OPERATING CASH FLOW(Y) Lowest at EUR 6.82 MM
  • NET PROFIT(Q) At EUR -0.62 MM has Fallen at -248.02%
  • INTEREST(Q) Highest at EUR 7.23 MM
2

With ROE of 1.15%, it has a Very Expensive valuation with a 3.19 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 300 Million ()

stock-summary
P/E

278.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.94

stock-summary
Return on Equity

1.15%

stock-summary
Price to Book

3.17

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.63%
0%
1.63%
6 Months
4.17%
0%
4.17%
1 Year
101.61%
0%
101.61%
2 Years
72.65%
0%
72.65%
3 Years
119.3%
0%
119.3%
4 Years
196.21%
0%
196.21%
5 Years
194.81%
0%
194.81%

Amplitude Surgical SAS for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.60%
EBIT Growth (5y)
1.18%
EBIT to Interest (avg)
0.41
Debt to EBITDA (avg)
5.32
Net Debt to Equity (avg)
0.94
Sales to Capital Employed (avg)
19.99
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
119.70%
ROE (avg)
4.43%
Valuation key factors
Factor
Value
P/E Ratio
278
Industry P/E
Price to Book Value
3.19
EV to EBIT
32.28
EV to EBITDA
15.73
EV to Capital Employed
2.13
EV to Sales
3.61
PEG Ratio
0.39
Dividend Yield
NA
ROCE (Latest)
6.61%
ROE (Latest)
1.15%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Amplitude Surgical SAS"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2023 is 14.38% vs 5.93% in Jun 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2023 is -142.86% vs 79.56% in Jun 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'23",
        "Jun'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "100.20",
          "val2": "87.60",
          "chgp": "14.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "26.80",
          "val2": "19.50",
          "chgp": "37.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.30",
          "val2": "13.60",
          "chgp": "-9.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.80",
          "val2": "-2.80",
          "chgp": "-142.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "138.00%",
          "val2": "76.90%",
          "chgp": "6.11%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Jun'23stock-summary
Jun'23
Jun'22
Change(%)
Net Sales
100.20
87.60
14.38%
Operating Profit (PBDIT) excl Other Income
26.80
19.50
37.44%
Interest
12.30
13.60
-9.56%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-6.80
-2.80
-142.86%
Operating Profit Margin (Excl OI)
138.00%
76.90%
6.11%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Jun 2023 is 14.38% vs 5.93% in Jun 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jun 2023 is -142.86% vs 79.56% in Jun 2022

stock-summaryCompany CV
About Amplitude Surgical SAS stock-summary
stock-summary
Amplitude Surgical SAS
Pharmaceuticals & Biotechnology
Amplitude Surgical SA is a France-based company engaged in the field of orthopedic surgeries. The Company offers the AMPLIVISION system, a computer navigation workstation and its related software, which is fully developed by the Company in collaboration with surgeons. Each implant is validated mechanically by creating models and running tests on simulators. Amplitude Surgical SAS relies on the expertise of its design offices and on scientific partnerships to internally design and develop its implants and automatic or computer-navigated instruments. It operates through ofab Orthopedie, a strategic industrial subcontractor
Company Coordinates stock-summary
Company Details
11 Cours Jacques Offenbach , VALENCE None : 26000
Registrar Details